December 17, 2017 - By Hazel Jackson
Venbio Select Advisor Llc increased its stake in Aveo Pharmaceuticals Inc (AVEO) by 68.42% based on its latest 2017Q2 regulatory filing with the SEC. Venbio Select Advisor Llc bought 2.69 million shares as the company’s stock declined 7.05% while stock markets rallied. The institutional investor held 6.63M shares of the health care company at the end of 2017Q2, valued at $14.72M, up from 3.94 million at the end of the previous reported quarter. Venbio Select Advisor Llc who had been investing in Aveo Pharmaceuticals Inc for a number of months, seems to be bullish on the $451.60 million market cap company. The stock increased 0.34% or $0.01 during the last trading session, reaching $2.94. About 1.30M shares traded. AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) has declined 16.67% since December 17, 2016 and is downtrending. It has underperformed by 33.37% the S&P500.
Crescent Park Management Lp increased its stake in Td Ameritrade Hldg Corp (AMTD) by 4.31% based on its latest 2017Q2 regulatory filing with the SEC. Crescent Park Management Lp bought 40,872 shares as the company’s stock declined 15.13% while stock markets rallied. The institutional investor held 989,642 shares of the investment bankers and brokers and service company at the end of 2017Q2, valued at $42.55 million, up from 948,770 at the end of the previous reported quarter. Crescent Park Management Lp who had been investing in Td Ameritrade Hldg Corp for a number of months, seems to be bullish on the $29.47 billion market cap company. The stock increased 2.16% or $1.1 during the last trading session, reaching $51.98. About 5.17 million shares traded or 155.92% up from the average. TD Ameritrade Holding Corporation (NYSE:AMTD) has risen 21.10% since December 17, 2016 and is uptrending. It has outperformed by 4.40% the S&P500.
Venbio Select Advisor Llc, which manages about $380.08M and $791.97M US Long portfolio, decreased its stake in Aerie Pharmaceuticals Inc (NASDAQ:AERI) by 194,158 shares to 230,842 shares, valued at $12.13 million in 2017Q2, according to the filing. It also reduced its holding in Acadia Pharmaceuticals Inc (NASDAQ:ACAD) by 1.02 million shares in the quarter, leaving it with 614,200 shares, and cut its stake in Fortress Biotech Inc.
Investors sentiment decreased to 1.09 in 2017 Q2. Its down 1.18, from 2.27 in 2017Q1. It worsened, as 13 investors sold AVEO shares while 9 reduced holdings. 15 funds opened positions while 9 raised stakes. 63.58 million shares or 13.08% more from 56.22 million shares in 2017Q1 were reported. Pura Vida Ltd Limited Liability Company holds 0.09% or 100,000 shares in its portfolio. Morgan Stanley owns 24,293 shares. 683 Capital Management Llc owns 3.34M shares. Cubist Systematic Strategies has invested 0% in AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO). Edge Wealth Mgmt Lc holds 0.01% of its portfolio in AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) for 10,000 shares. Point72 Asset Ltd Partnership invested 0.04% in AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO). Venbio Select Advisor Ltd Company invested 1.86% of its portfolio in AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO). Perceptive Advisors Limited reported 0.67% of its portfolio in AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO). New Leaf Venture Prtnrs Limited Liability Corporation stated it has 3.09 million shares. Fore Research Management Lp holds 0.05% of its portfolio in AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) for 50,000 shares. Northern Trust Corporation has invested 0% in AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO). Vanguard Group Inc reported 3.55 million shares stake. Evercore Wealth Ltd Llc reported 0.01% in AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO). Jane Street Group Inc Llc owns 82,686 shares. Deer Vi And Co Llc holds 100% or 675,242 shares in its portfolio.
Among 3 analysts covering AVEO Pharmaceuticals (NASDAQ:AVEO), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. AVEO Pharmaceuticals had 10 analyst reports since March 30, 2016 according to SRatingsIntel. FBR Capital maintained AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) rating on Thursday, December 7. FBR Capital has “Buy” rating and $5.0 target. FBR Capital initiated the stock with “Outperform” rating in Wednesday, March 30 report. The company was maintained on Wednesday, August 9 by Piper Jaffray. The stock of AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) earned “Buy” rating by Piper Jaffray on Monday, August 28. Piper Jaffray initiated the shares of AVEO in report on Thursday, May 19 with “Overweight” rating. The company was maintained on Monday, June 26 by FBR Capital. Piper Jaffray maintained the stock with “Buy” rating in Thursday, October 5 report.
Crescent Park Management Lp, which manages about $466.84M and $531.80 million US Long portfolio, decreased its stake in Mckesson Corp (NYSE:MCK) by 3,300 shares to 63,600 shares, valued at $10.47 million in 2017Q2, according to the filing.
Investors sentiment is 1.05 in 2017 Q2. Its the same as in 2017Q1. It is without change, as 37 investors sold AMTD shares while 83 reduced holdings. only 34 funds opened positions while 92 raised stakes. 477.60 million shares or 0.81% more from 473.79 million shares in 2017Q1 were reported. 1,121 were accumulated by Ameritas Prtnrs. Balyasny Asset Limited Liability Corporation holds 0.05% of its portfolio in TD Ameritrade Holding Corporation (NASDAQ:AMTD) for 274,146 shares. World Asset Mngmt has 0.02% invested in TD Ameritrade Holding Corporation (NASDAQ:AMTD). Goldman Sachs Group reported 1.44M shares. Finance Architects invested 0% in TD Ameritrade Holding Corporation (NASDAQ:AMTD). Pictet Asset Mngmt, United Kingdom-based fund reported 97,800 shares. 3,254 were accumulated by Valley Advisers. Walter & Keenan Fincl Consulting Com Mi Adv has invested 0.19% in TD Ameritrade Holding Corporation (NASDAQ:AMTD). Virtu Fin Ltd Co reported 6,778 shares stake. M&T Bankshares Corporation accumulated 11,882 shares. Cornerstone Advsr holds 673 shares or 0.02% of its portfolio. City Holdings Co holds 415 shares or 0.01% of its portfolio. Wells Fargo Mn reported 0.04% of its portfolio in TD Ameritrade Holding Corporation (NASDAQ:AMTD). 19.45 million are held by Baillie Gifford And. Federated Inc Pa invested 0% in TD Ameritrade Holding Corporation (NASDAQ:AMTD).
Since September 14, 2017, it had 1 insider buy, and 1 insider sale for $399.33 million activity. Another trade for 15,000 shares valued at $669,900 was sold by MOGLIA JOSEPH H.
Among 18 analysts covering TD Ameritrade (NYSE:AMTD), 7 have Buy rating, 1 Sell and 10 Hold. Therefore 39% are positive. TD Ameritrade had 65 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Equal-Weight” rating given on Tuesday, July 25 by Morgan Stanley. Wells Fargo upgraded TD Ameritrade Holding Corporation (NASDAQ:AMTD) on Monday, May 15 to “Outperform” rating. On Thursday, October 5 the stock rating was maintained by Jefferies with “Hold”. Barclays Capital maintained the shares of AMTD in report on Tuesday, August 9 with “Equal-Weight” rating. The rating was maintained by Wood on Thursday, April 13 with “Hold”. The rating was initiated by Keefe Bruyette & Woods with “Mkt Perform” on Thursday, December 8. The stock of TD Ameritrade Holding Corporation (NASDAQ:AMTD) has “Sell” rating given on Thursday, November 30 by Credit Suisse. Nomura maintained the shares of AMTD in report on Thursday, July 13 with “Buy” rating. Credit Suisse upgraded the shares of AMTD in report on Friday, February 3 to “Outperform” rating. The stock of TD Ameritrade Holding Corporation (NASDAQ:AMTD) has “Hold” rating given on Monday, June 27 by Jefferies.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.